- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07633964
An Study Looking at Percutaneous Coronary Intervention Outcomes for Octogenarians
June 3, 2026 updated by: Fiona Macrae, Gloucestershire Hospitals NHS Foundation Trust
An Observational Study Looking at the Demographics and Outcomes of Octogenarians Undergoing Percutaneous Coronary Intervention (PCI) Over a Seven-year Period at a Primary Percutaneous Coronary Intervention (PPCI) Centre With Off-site Cardiothoracic Support
The goal of this observational study is to understand the makeup of the participants aged 80 years and older who had stents fitted or balloon expansion of their heart arteries, otherwise known as percutaneous coronary intervention (PCI), at our hospital over a seven year period.
The investigators will aim to describe the cohort with respect to their health conditions, age and frailty in addition to whether their procedure was planned or an emergency.
The investigators will also look at the outcomes of these participants up to one year post procedure.
The secondary aim is to look for associations between participant variables and their outcomes in hospital and at 1 year.
The specific outcomes the investigators will look at are: inpatient complications and the incidence of heart attacks, strokes, unplanned PCI, cardiac rehospitalisation or death.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The project is a retrospective observational study designed to look at the demographics, clinical presentation, comorbidities, angiographic findings, procedural factors and outcomes of participants aged 80 years and over (octogenarians) who had percutaneous coronary intervention (PCI) at our hospital trust between 1st January 2017 and 31st December 2023.
The data will be reviewed to form a detailed description of the characteristics of the cohort.
It will then be analysed to determine if there are associations between certain participant variables and outcomes, including inpatient complication rates and the rate of Major Adverse Cardiovascular Events (MACE) at one-year post procedure.
The initial data will be identified from the local database which is required to be maintained and submitted to the UK's National Institute for Cardiovascular Outcomes Research (NICOR) database.
Missing data or additional data not captured on this database, such as participant frailty and the coronary artery disease severity and complexity (measured by the SYNTAX score), will be collected from a combination of patient letters and Electronic Patient Records (EPR), including blood test results and imaging.
Experienced interventional cardiologists will analyse the angiograms to collect the pre and post intervention SYNTAX score in addition to the angiography-derived calcification severity of the culprit artery.
The data will be analysed to describe the cohort in detail.
Univariate and multivariate cox regression analysis will be used to establish any associations between variables such as participant frailty, angiography-derived calcification severity and residual SYNTAX score with participant outcomes.
Study Type
Observational
Enrollment (Estimated)
850
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gloucestershire
-
Gloucester, Gloucestershire, United Kingdom, GL1 3NN
- Gloucestershire Hospitals NHS Foundation Trust
-
Contact:
- R&I Professional Services Manager
- Phone Number: +44 300 422 5460
- Email: chris.ford1@nhs.net
-
Principal Investigator:
- Fiona Macrae, MBBS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Participants who had PCI at our hospital trust between 1st January 2017 - 31st December 2023 and were aged 80 years and older.
Description
Inclusion Criteria:
- Participants who had PCI at our hospital trust between 1st January 2017 - 31st December 2023.
Exclusion Criteria:
- Participants with negative pressure wire studies (i.e. the lesion identified was not flow restricting).
- Participants had "failed PCI".
- Participants with significantly incomplete data despite thorough review of the electronic records.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Octogenarians who had PCI between 2017-2023
|
Percutaneous Coronary Intervention for example balloon angioplasty and balloon angioplasty with stent insertion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Myocardial infarction
Time Frame: 1 year
|
Number of participants who suffered a myocardial infarction post-procedure.
|
1 year
|
|
Unplanned revascularisation
Time Frame: 1 year
|
The number of participants who had unplanned revascularisation.
|
1 year
|
|
Cerebrovascular accident
Time Frame: 1 year.
|
The number of participants who suffered a cerebrovascular accident
|
1 year.
|
|
Unplanned cardiac readmission
Time Frame: 1 year.
|
The number of participants who had an unplanned readmission to the cardiac ward.
|
1 year.
|
|
Death
Time Frame: 1 year
|
Death from any cause.
|
1 year
|
|
Arterial complication
Time Frame: 1 year.
|
The number of participants who suffered an inpatient arterial complication.
|
1 year.
|
|
Blood transfusion
Time Frame: 1 year.
|
The number of participants who required an inpatient blood transfusion.
|
1 year.
|
|
Renal replacement therapy
Time Frame: 1 year.
|
The number of participants who required inpatient renal replacement therapy.
|
1 year.
|
|
Gastrointestinal bleed
Time Frame: 1 year
|
The number of participants who suffered an upper gastrointestinal bleed.
|
1 year
|
|
Tamponade
Time Frame: 1 year
|
The number of participants who experienced an inpatient cardiac tamponade.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2027
Study Registration Dates
First Submitted
May 25, 2026
First Submitted That Met QC Criteria
June 3, 2026
First Posted (Actual)
June 8, 2026
Study Record Updates
Last Update Posted (Actual)
June 8, 2026
Last Update Submitted That Met QC Criteria
June 3, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25/085/GHT
- 26/WM/0104 (Other Identifier: REC Number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
It has not been stated within the ethical approval for this study that the investigators will share the data with other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardio Vascular Disease
-
National Taiwan University HospitalJohnson & JohnsonEnrolling by invitationCardio Vascular Disease | CryoablationTaiwan
-
Nanjing Medical UniversityWest China Hospital; The Affiliated Hospital of Qingdao University; Beijing Anzhen... and other collaboratorsNot yet recruitingCardiopulmonary Bypass | Cardio Vascular DiseaseChina
-
Alliance For Medical Research in AfricaInstitut Pasteur de DakarActive, not recruitingCancer | Mortality | Cardiovascular | Cardio Vascular DiseaseSenegal
-
University Hospital, MontpellierTerminated
-
The University of Hong KongRecruitingExercise | Fitness Trackers | Cardio Vascular Disease | Physical Activities | Health CoachingHong Kong
-
Chinese University of Hong KongRecruitingHyperlipidemia | Cardio Vascular DiseaseHong Kong
-
SINA Health Education and Welfare TrustAga Khan UniversityNot yet recruitingHypertension | Self Care | Cardio Vascular Disease | Educational Intervention | Video Streaming
-
Mahdi MutaharImperial College London; Temple University; Loughborough UniversityRecruitingVascular Dysfunction | Cardio Vascular Disease | Endothelial Function and Arterial Stiffness | Periodontal Disease (PD) | Oral-Systemic LinkUnited Kingdom
-
Fondation Hôpital Saint-JosephRecruitingCardio Vascular DiseaseFrance
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Institut Catala de SalutNot yet recruitingAtrial Fibrillation (AF) | Electronic Health Records | Cardio Vascular Disease | MACE | Cost-effectiveness Analysis | Cardio-cerebrovascular Disease | Artificial Intelligence (AI) | Quality-adjusted Life-years | Thromboembolic RiskSpain
Clinical Trials on Percutaneous Coronary Intervention
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedCoronary Artery DiseaseChina
-
University Hospital, SaarlandCompletedAcute Myocardial InfarctionGermany
-
University Hospital of PatrasCompletedCoronary Artery Bypass SurgeryGreece
-
Yonsei UniversityUnknownCoronary Artery Disease | Stable Angina | Unstable AnginaKorea, Republic of
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
RobocathCompletedCoronary Artery Disease | Percutaneous Coronary InterventionFrance, Belgium, Luxembourg, Netherlands
-
Herlev and Gentofte HospitalUnknownCoronary Heart Disease | Ischemic Heart Disease | Stable AnginaDenmark
-
University College, LondonNational Institute for Cardiovascular Outcomes Research; British Cardiovascular... and other collaboratorsCompletedPercutaneous Coronary InterventionUnited Kingdom
-
Corindus Inc.CompletedMyocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive DiseasesUnited States, Israel
-
Chinese PLA General HospitalUnknownPercutaneous Coronary Intervention | CHD - Coronary Heart Disease | In-stent RestenosisChina